Insulin-like growth factor 2 (IGF2) protects against Huntington’s disease through the extracellular disposal of protein aggregates
Authors:
- Paula García-HuertaPGPaula García-Huerta
- Paulina Troncoso-EscuderoPTPaulina Troncoso-Escudero
- Arun ThiruvalluvanATArun Thiruvalluvan
- Marisol CisternasMCMarisol Cisternas
- Daniel R. HenríquezDHDaniel R. Henríquez
- Lars PlateLPLars Plate
- Pedro Chana-CuevasPedro Chana-Cuevas
- Cristian SaquelCSCristian Saquel
- Peter ThielenPTPeter Thielen
- Kenneth A. LongoKLKenneth A. Longo
- Brad J. GeddesBGBrad J. Geddes
Preprint
Abstract
Impaired neuronal proteostasis is a salient feature of many neurodegenerative diseases, highlighting alterations in the function of the endoplasmic reticulum (ER). We previously reported that targeting the transcription factor XBP1, a key mediator of the ER stress response, delays disease progression and reduces protein aggregation in various models of neurodegeneration. To identify disease-modifier genes that may explain the neuroprotective effects of XBP1 deficiency, we performed gene expression profiling of brain cortex and striatum of these animals and uncovered insulin-like growth factor 2 ( Igf2 ) as the major upregulated gene. Here we studied the impact of IGF2 signaling on protein aggregation in models of Huntington’s disease (HD) as proof-of-concept. Cell culture studies revealed that IGF2 treatment decreases the load of intracellular aggregates of mutant huntingtin and a polyglutamine peptide. These results were validated using induced pluripotent stem cells (iPSC)-derived medium spiny neurons from HD patients. The reduction in the levels of mutant huntingtin was associated with a decrease in the half-life of the intracellular protein. The decrease in the levels of abnormal protein aggregation triggered by IGF2 were independent of the activity of autophagy and the proteasome pathways, the two main routes for mutant huntingtin clearance. Conversely, IGF2 signaling enhanced the secretion of soluble mutant huntingtin species through exosomes and microvesicles involving changes in actin dynamics. Administration of IGF2 into the brain of HD mice using gene therapy led to a significant decrease in the levels of mutant huntingtin in three different animal models. Moreover, analysis of human post-mortem brain tissue, and blood samples from HD patients showed a reduction of IGF2 level. This study identifies IGF2 as a relevant factor deregulated in HD, operating as a disease modifier that buffers the accumulation of abnormal protein aggregates. One sentence summary: IGF2 reduces the load of intracellular protein aggregates through the extracellular disposal of the mutant protein.Keywords
All Related Versions
- Published version: Acta Neuropathologica, 140 (5), 737.
This publication has 109 references indexed in Scilit:
- Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2Trends in Neurosciences, 2012
- Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagyHuman Molecular Genetics, 2012
- A hippocampal insulin‐growth factor 2 pathway regulates the extinction of fear memoriesThe EMBO Journal, 2011
- Insulin/IGF-1 signaling mutants reprogram ER stress response regulators to promote longevityProceedings of the National Academy of Sciences, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010
- Neural transplants in patients with Huntington's disease undergo disease-like neuronal degenerationProceedings of the National Academy of Sciences, 2009
- Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy ApproachJournal of Medicinal Chemistry, 2009
- Lifeact: a versatile marker to visualize F-actinNature Methods, 2008
- Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesisProceedings of the National Academy of Sciences, 2008
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001